Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Hormonal Regulation and Hypertension, Diabetes, Cardiovascular Risks, and Lipoproteins, and Cholesterol and Lipid Metabolism.
Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.
Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis.
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce Atherosclerosis.
Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemia.
Recurrent acute coronary syndrome caused by a primary aortic valve sarcoma: grand rounds and literature review.
The Cholesterol Uptake Capacity: The search for scalable HDL function tests continues.
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels
Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
HDL cholesterol and ASCVD risk stratification: A debate.
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
ABCA1 Agonist Mimetic Peptide CS-6253 Induces Microparticles Release From Different Cell Types by ABCA1-Efflux-Dependent Mechanism.
The Lifelong Burden of Homozygous Familial Hypercholesterolemia.
Smashing Low-Density Lipoprotein Levels and Preventing Coronary Allograft Vasculopathy: One Heart Transplant Patient at a Time.
Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
Chylomicrons: When you can't direct the wind, adjust the sail.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Residual macrovascular risk in 2013: what have we learned?
Reducing the burden of disease and death from familial hypercholesterolemia: A call to action
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia